Mirae Asset Global ETFs Holdings’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.66M Sell
21,557
-39,219
-65% -$7.5M 0.01% 888
2026
Q1
$11.1M Buy
60,776
+2,940
+5% +$542K 0.02% 622
2025
Q4
$10.2M Sell
57,836
-79,024
-58% -$12.9M 0.02% 637
2025
Q3
$19.2M Sell
136,860
-2,972
-2% -$402K 0.03% 447
2025
Q2
$17.6M Sell
139,832
-4,761
-3% -$593K 0.03% 422
2025
Q1
$19.8M Buy
144,593
+27,353
+23% +$3.91M 0.04% 397
2024
Q4
$17.9M Sell
117,240
-14,148
-11% -$2.39M 0.04% 405
2024
Q3
$25.5M Buy
131,388
+3,327
+3% +$696K 0.06% 315
2024
Q2
$29.7M Buy
+128,061
New +$27.8M 0.07% 274

Other funds holding BIIB

Mirae Asset Global ETFs Holdings's BIIB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Biogen (BIIB) stake by 65% in Q2 2026, selling an estimated $7.5M and leaving 21,557 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #888.

Mirae Asset Global ETFs Holdings first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. The position peaked at $29.7M in Q2 2024. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 21,557 shares of Biogen worth $4.66M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 39,219 Biogen shares in Q2 2026, an estimated $7.5M.
  • Biogen made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #888 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Biogen position peaked at $29.7M in Q2 2024.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.